These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31180972)

  • 1. Conquering the Craving: Treatment to Curb Alcohol Use Disorder.
    J Christ Nurs; 2019; 36(3):E49-E50. PubMed ID: 31180972
    [No Abstract]   [Full Text] [Related]  

  • 2. Conquering the Craving: Treatment to Curb Alcohol Use Disorder.
    Umhau JC
    J Christ Nurs; 2019; 36(3):148-156. PubMed ID: 31180959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug reduces alcohol craving.
    Nurse Pract; 1999 Feb; 24(2):104. PubMed ID: 10048082
    [No Abstract]   [Full Text] [Related]  

  • 4. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial.
    Hendershot CS; Dermody SS; Wardell JD; Zaso MJ; Kennedy JL; Stoner SA
    Alcohol Clin Exp Res; 2020 Apr; 44(4):983-991. PubMed ID: 32020635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain.
    Health News; 2005 Dec; 11(12):6-7. PubMed ID: 16416546
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
    Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
    J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chat Room.
    Walker C; Schmidt K
    J Christ Nurs; 2019; 36(3):199. PubMed ID: 31180968
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy for alcohol dependence.
    West SL; Garbutt JC; Carey TS; Lux LJ; Jackman AM; Tolleson-Rinehart S; Lohr KN; Crews FT
    Evid Rep Technol Assess (Summ); 1999 Jan; (3):1-5. PubMed ID: 11487800
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anesthetic considerations in a patient taking disulfiram and naltrexone for chronic alcoholism].
    del Blanco Narciso BB; Orts Castro A; Calvo Vecino JM
    Rev Esp Anestesiol Reanim; 2011 Feb; 58(2):128-9. PubMed ID: 21427831
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone in alcohol dependence.
    Brewer C
    Lancet; 1995 Nov; 346(8986):1374. PubMed ID: 7475809
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
    Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
    Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
    Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Naltrexone in the treatment of alcohol dependence].
    Ochoa Mangado E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):51-7. PubMed ID: 9549136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faith Community Nursing: Faith Element Enhances Cardiovascular Risk Reduction Program Outcomes.
    May I; George N
    J Christ Nurs; 2021; 38(1):38-46. PubMed ID: 33284216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention.
    Dermody SS; Wardell JD; Stoner SA; Hendershot CS
    Ann Behav Med; 2018 Aug; 52(9):787-797. PubMed ID: 30124761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.